Treatment of Helicobacter Pylori Infected Mice with Bryophyllum Pinnatum, a Medicinal Plant with Antioxidant and Antimicrobial Properties, Reduces Bacterial Load
Overview
Authors
Affiliations
Context: Bryophyllum pinnatum (Lam.) Kurz (Crassulaceae) is a plant known for its antiulcer properties.
Objective: This study evaluates the anti-Helicobacter pylori activity of Bryophyllum pinnutum methanol extract with a mouse model and its antioxidant properties.
Materials And Methods: Dried leaves of Bryophyllum pinnutum were extracted with methanol and ethyl acetate. Broth microdilution method was used to evaluate the anti-Helicobacter activity of extract samples in vitro. Swiss mice were inoculated with a suspension of Helicobacter pylori and divided into control group and four others that received 125, 250, 500 mg/kg of methanol extract or ciprofloxacin (500 mg/kg), respectively, for 7 days. Helicobacter pylori colonization and bacterial load of mouse stomach was assessed on day 1 and 7 post-treatment. The antioxidant activity of Bryophyllum pinnutum was evaluated through DPPH radical, hydroxyl radical and reducing power assay.
Results: Methanol extract showed a significant anti-Helicobacter activity with MIC and MBC values of 32 and 256 μg/mL, respectively. Bryophyllum pinnatum and ciprofloxacin reduced H. pylori colonization of gastric tissue from 100% to 17%. Bryophyllum pinnatum extract (85.91 ± 52.91 CFU) and standard (25.74 ± 16.15 CFU) also reduced significantly (p < 0.05) bacterial load of gastric mucosa as compared to untreated infected mice (11883 ± 1831 CFU). DPPH radical, hydroxyl radical and reducing power assays showed IC values of 25.31 ± 0.34, 55.94 ± 0.68 and 11.18 ± 0.74 μg/mL, respectively.
Discussion And Conclusion: The data suggest that the methanol extract of Bryophyllum pinnatum could inhibit Helicobacter pylori growth, and may also acts as an antioxidant to protect gastric mucosa against reactive oxygen species.
Plants with Anti-Ulcer Activity and Mechanism: A Review of Preclinical and Clinical Studies.
Prayoga D, Aulifa D, Budiman A, Levita J Drug Des Devel Ther. 2024; 18:193-213.
PMID: 38318501 PMC: 10840521. DOI: 10.2147/DDDT.S446949.
infection in humans and phytotherapy, probiotics, and emerging therapeutic interventions: a review.
Liu M, Gao H, Miao J, Zhang Z, Zheng L, Li F Front Microbiol. 2024; 14:1330029.
PMID: 38268702 PMC: 10806011. DOI: 10.3389/fmicb.2023.1330029.
Review of Phytochemical Potency as a Natural Anti- and Neuroprotective Agent.
Tandoro Y, Chen B, Ali A, Wang C Molecules. 2023; 28(20).
PMID: 37894629 PMC: 10609179. DOI: 10.3390/molecules28207150.
Al-Fakhrany O, Elekhnawy E Arch Microbiol. 2023; 205(9):301.
PMID: 37550555 PMC: 10406680. DOI: 10.1007/s00203-023-03639-0.
Promising anti- and anti-inflammatory metabolites from unused parts of CV 'Zaghloul': and study.
Elhefni N, Ebada S, Abdel-Aziz M, Marwan E, El-Sharkawy S, El-Neketi M Pharm Biol. 2023; 61(1):657-665.
PMID: 37092359 PMC: 10128457. DOI: 10.1080/13880209.2023.2200841.